AVITA Medical, Inc. (AVHHL)
OTCMKTS · Delayed Price · Currency is USD
1.115
-0.135 (-10.80%)
At close: Oct 8, 2025
AVITA Medical Employees
AVITA Medical had 260 employees as of December 31, 2024. The number of employees increased by 53 or 25.60% compared to the previous year.
Employees
260
Change (1Y)
53
Growth (1Y)
25.60%
Revenue / Employee
$288,015
Profits / Employee
-$198,358
Market Cap
118.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 260 | 53 | 25.60% |
| Dec 31, 2023 | 207 | 81 | 64.29% |
| Dec 31, 2022 | 126 | 10 | 8.62% |
| Dec 31, 2021 | 116 | 8 | 7.41% |
| Jun 30, 2021 | 108 | 10 | 10.20% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
AVITA Medical News
- 14 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - PRNewsWire
- 15 days ago - AVITA Medical (RCEL) Shares Plummet as Interim CEO Appointed - GuruFocus
- 15 days ago - RCEL: Lake Street Downgrades AVITA Medical to Hold, PT Slashed by 50% | RCEL Stock News - GuruFocus
- 15 days ago - Avita Medical (RCEL) Forecasts $17 Million in Q3 Revenue - GuruFocus
- 15 days ago - AVITA Medical (RCEL) Appoints Interim CEO and Updates Revenue Guidance - GuruFocus
- 15 days ago - AVITA Medical Appoints Cary Vance As Interim CEO - Nasdaq
- 15 days ago - AVITA Medical Announces CEO Transition - GlobeNewsWire
- 15 days ago - AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders - GlobeNewsWire